Medical Specialty

Internal Medicine

Aficamten Shows Major Promise for Nonobstructive HCM - OC Academy Medical Insights

Aficamten Shows Major Promise for Nonobstructive HCM

Discover how aficamten improves exercise capacity and quality of life in nonobstructive hypertrophic cardiomyopathy based on ACACIA-HCM trial findings.

Aug 29, 2026
2 min read
Can Tailored Antibiotics Shorten Endocarditis Therapy? - OC Academy Medical Insights

Can Tailored Antibiotics Shorten Endocarditis Therapy?

The POET-II trial reveals that response-tailored antibiotic therapy safely shortens infective endocarditis treatment duration in clinically stable adults.

Aug 29, 2026
2 min read
AI-ECG System Detects Transthyretin Amyloid Cardiomyopathy - OC Academy Medical Insights

AI-ECG System Detects Transthyretin Amyloid Cardiomyopathy

Discover how deep learning AI applied to routine ECGs enables rapid transthyretin amyloid cardiomyopathy screening and prioritizes advanced imaging.

Aug 29, 2026
2 min read
2025 Adult Obesity Guidelines: Modern Care & GLP-1 Use - OC Academy Medical Insights

2025 Adult Obesity Guidelines: Modern Care & GLP-1 Use

Discover the 2025 adult obesity management guideline updates, featuring revised screening cutoffs, GLP-1 therapies, and long-term treatment strategies.

Aug 26, 2026
2 min read
Modern Adult Obesity Management: New VA/DoD Guidelines - OC Academy Medical Insights

Modern Adult Obesity Management: New VA/DoD Guidelines

Discover the updated 2025 VA/DoD clinical guidelines for adult obesity management, highlighting flexible pharmacotherapy and comprehensive lifestyle care.

Aug 25, 2026
2 min read
Daily Zinc Cuts Infection Risk in Pediatric Sickle Cell - OC Academy Medical Insights

Daily Zinc Cuts Infection Risk in Pediatric Sickle Cell

Explore findings from the ZIPS-2 trial showing daily zinc supplementation reduces infection rates in young children with sickle cell anemia.

Aug 20, 2026
2 min read
STArT Trial: Does IV Arginine Shorten Sickle Cell Pain? - OC Academy Medical Insights

STArT Trial: Does IV Arginine Shorten Sickle Cell Pain?

STArT trial finds IV arginine does not reduce time to crisis resolution or opioid use in pediatric sickle cell disease acute pain episodes. Read key findings.

Aug 20, 2026
2 min read
Targeted Therapies in Myeloproliferative Neoplasms - OC Academy Medical Insights

Targeted Therapies in Myeloproliferative Neoplasms

Explore the genetic drivers, clonal evolution, and targeted therapies in myeloproliferative neoplasms to optimize long-term patient outcomes.

Aug 20, 2026
2 min read
Randomized QI Trials: A Novel Ethical Oversight Guide - OC Academy Medical Insights

Randomized QI Trials: A Novel Ethical Oversight Guide

Explore how randomized quality improvement trials optimize healthcare delivery through ethical oversight, practical randomization, and active monitoring.

Aug 19, 2026
3 min read
How Tracking Heart Stress Predicts Longevity and CVD Risk - OC Academy Medical Insights

How Tracking Heart Stress Predicts Longevity and CVD Risk

Discover how longitudinal NT-proBNP heart stress assessment improves risk prediction for cardiovascular disease and mortality in older adults.

Aug 19, 2026
2 min read
Indian doctor discussing Evidence-Based Tobacco Cessation Strategies for LMICs

Evidence-Based Tobacco Cessation Strategies for LMICs

Explore evidence-based tobacco cessation strategies in LMICs like India, combining MPOWER, Ask-Advise-Connect models, NRT, and digital support.

Aug 13, 2026
3 min read
Indian doctor discussing Perioperative Cardiovascular Risk in Noncardiac Surgery

Perioperative Cardiovascular Risk in Noncardiac Surgery

Learn key strategies to manage perioperative cardiovascular risk in patients undergoing noncardiac surgery based on the latest 2024 AHA/ACC guidelines.

Aug 12, 2026
3 min read
Indian doctor discussing Surgical Fusion vs Watchful Waiting in Hallux Rigidus

Surgical Fusion vs Watchful Waiting in Hallux Rigidus

A randomized trial proves first MTPJ arthrodesis significantly reduces walking pain in severe hallux rigidus compared to watchful waiting at 12 months.

Aug 12, 2026
3 min read
Indian doctor discussing Comprehensive IBD Health Maintenance in Primary Practice

Comprehensive IBD Health Maintenance in Primary Practice

Discover essential IBD health maintenance strategies, including vaccinations, cancer screening, bone health, and collaborative primary care management.

Aug 12, 2026
3 min read
Indian doctor discussing DOACs vs Warfarin in Atrial Fibrillation Mitral Stenosis

DOACs vs Warfarin in Atrial Fibrillation Mitral Stenosis

A recent study evaluates DOACs versus warfarin in atrial fibrillation and mitral stenosis, showing higher stroke risk but lower MI risk with DOACs.

Aug 12, 2026
3 min read
Indian doctor discussing Asundexian Redefines Secondary Ischemic Stroke Prevention

Asundexian Redefines Secondary Ischemic Stroke Prevention

Asundexian stroke prevention reduces recurrent ischemic stroke risk without increasing major bleeding risk when added to antiplatelet therapy after TIA.

Aug 5, 2026
3 min read
Indian doctor discussing How Blood Pressure-Lowering Drugs Protect Heart in CKD

How Blood Pressure-Lowering Drugs Protect Heart in CKD

A major study confirms that blood pressure-lowering drugs reduce major cardiovascular events across all stages of chronic kidney disease regardless of G category.

Aug 5, 2026
3 min read
Indian doctor discussing Sacubitril vs Dapagliflozin: HF Health Status at 6 Months

Sacubitril vs Dapagliflozin: HF Health Status at 6 Months

A randomized trial comparing sacubitril-valsartan vs dapagliflozin and torsemide vs furosemide showed no difference in HF health status at six months.

Aug 5, 2026
3 min read
Indian doctor discussing Whole Health Teams Outperform CBT for Chronic Pain Care

Whole Health Teams Outperform CBT for Chronic Pain Care

A 12-month study shows whole health team care reduces pain interference more than CBT or usual care in veterans with chronic pain management needs.

Aug 5, 2026
3 min read
Indian doctor discussing EVT Improves Outcomes in Large-Core Ischemic Stroke

EVT Improves Outcomes in Large-Core Ischemic Stroke

Recent clinical evidence shows endovascular thrombectomy improves 90-day functional outcomes and survival in large core ischemic stroke within 24 hours.

Aug 5, 2026
3 min read
Indian doctor discussing Asundexian Prevents Recurrent Stroke Without Bleeding

Asundexian Prevents Recurrent Stroke Without Bleeding

Discover how asundexian stroke prevention reduces recurrent ischemic stroke by 26% without increasing major bleeding risk in acute noncardioembolic TIA.

Aug 4, 2026
3 min read
Indian doctor discussing Why CKD Blood Pressure Control Is Crucial for Heart Health

Why CKD Blood Pressure Control Is Crucial for Heart Health

Lowering blood pressure reduces major cardiovascular risk across all CKD stages. Explore new clinical findings on cardiorenal protection for your patients.

Aug 4, 2026
3 min read
Indian doctor discussing Symptomatic Heart Failure: Comparing 6-Month Outcomes

Symptomatic Heart Failure: Comparing 6-Month Outcomes

A study compares sacubitril-valsartan, dapagliflozin, torsemide, and furosemide for 6-month health status outcomes in symptomatic heart failure.

Aug 4, 2026
3 min read
Indian doctor discussing Why Whole Health Teams Outperform CBT in Chronic Pain Care

Why Whole Health Teams Outperform CBT in Chronic Pain Care

Discover how a whole health team approach improves chronic pain management more effectively than CBT or usual medical care.

Aug 4, 2026
3 min read
Indian doctor discussing EVT vs Medical Therapy in Large-Core Ischemic Stroke

EVT vs Medical Therapy in Large-Core Ischemic Stroke

Endovascular thrombectomy within 24 hours improves functional outcomes and reduces 90-day mortality in large-core ischemic stroke vs medical care.

Aug 4, 2026
3 min read
Indian doctor discussing Doravirine Regimen Reduces Weight Gain in Initial HIV Care

Doravirine Regimen Reduces Weight Gain in Initial HIV Care

The Opti-DOR trial shows doravirine-based HIV therapy limits treatment-associated weight gain while maintaining high viral suppression in adult patients.

Aug 1, 2026
3 min read
Indian doctor discussing Dapagliflozin Prevents Kidney Injury in Heart Surgery

Dapagliflozin Prevents Kidney Injury in Heart Surgery

A trial evaluated if dapagliflozin acute kidney injury reduction occurs in elective cardiac surgery. Discover key clinical outcomes and study insights.

Jul 31, 2026
3 min read
Indian doctor discussing How New US State Laws Transform IMG Medical Licensing

How New US State Laws Transform IMG Medical Licensing

US states are enacting historic laws to streamline IMG medical licensing, removing mandatory domestic residency requirements for foreign-trained doctors.

Jul 29, 2026
3 min read
Indian doctor discussing New US Licensing Pathways for Foreign-Trained Physicians

New US Licensing Pathways for Foreign-Trained Physicians

Learn how new state laws transform international medical graduate licensure in the United States and streamline career options.

Jul 28, 2026
3 min read
Indian doctor discussing Perioperative Enfortumab Vedotin-Pembrolizumab in MIBC

Perioperative Enfortumab Vedotin-Pembrolizumab in MIBC

Phase 3 trial shows perioperative enfortumab vedotin-pembrolizumab improves event-free and overall survival in cisplatin-eligible bladder cancer patients.

Jul 23, 2026
3 min read
Indian doctor discussing Why Home Dialysis Fails to Reach Patients Who Need It Most

Why Home Dialysis Fails to Reach Patients Who Need It Most

Explore the history of home dialysis barriers, political struggles, and socio-economic hurdles, with lessons for expanding dialysis access in India.

Jul 21, 2026
3 min read
Indian doctor discussing How to Master the New STROBE EPIC Reporting Standard

How to Master the New STROBE EPIC Reporting Standard

Discover how the new STROBE EPIC guideline changes reporting observational studies for incidence and prevalence, improving clinical research quality.

Jul 21, 2026
3 min read
Indian doctor discussing Olorofim: A Game-Changer for Intractable Fungal Infections

Olorofim: A Game-Changer for Intractable Fungal Infections

Discover how the novel antifungal olorofim offers a powerful new option for treating refractory and disseminated coccidioidomycosis in clinical trials.

Jul 21, 2026
3 min read
Indian doctor discussing Andes Virus Infection: Guidelines for Indian Doctors

Andes Virus Infection: Guidelines for Indian Doctors

Learn about Andes virus infection, its transmission, and expert clinical management guidelines tailored for healthcare providers and Indian clinicians.

Jul 16, 2026
3 min read
Indian doctor discussing Is Indefinite Myeloma Maintenance Therapy Finally Dead?

Is Indefinite Myeloma Maintenance Therapy Finally Dead?

The ENDURANCE trial shows that fixed-duration lenalidomide maintenance therapy has equal survival benefits to indefinite therapy with much lower toxicity.

Jul 16, 2026
3 min read
Indian doctor discussing Extended DAPT Prevents Heart Attacks in Multivessel CAD

Extended DAPT Prevents Heart Attacks in Multivessel CAD

Explore why extended dual antiplatelet therapy after DES implantation protects patients with multivessel CAD from heart attacks without increasing bleeding.

Jul 16, 2026
3 min read
Indian doctor discussing Are Healthcare-Associated Infections Falling in Hospitals?

Are Healthcare-Associated Infections Falling in Hospitals?

Explore the latest NEJM study on healthcare-associated infections. Discover how infection rates declined from 2015 to 2023 and what it means for doctors.

Jul 16, 2026
3 min read
Indian doctor discussing Effective Fibromyalgia Management in Modern Primary Care

Effective Fibromyalgia Management in Modern Primary Care

Explore modern fibromyalgia management strategies. Learn how central nervous system hyperresponsiveness is targeted to achieve clinical homeostasis.

Jul 16, 2026
3 min read
Indian doctor discussing GLP-1s and Optic Neuropathy: New Data Clarifies Risk

GLP-1s and Optic Neuropathy: New Data Clarifies Risk

Discover the actual ischemic optic neuropathy risk with GLP-1 receptor agonists in this new nationwide cohort study comparing GLP-1s to SGLT-2 inhibitors.

Jul 15, 2026
4 min read
Indian doctor discussing Do GLP-1 RAs Truly Help Patients Stop Basal Insulin?

Do GLP-1 RAs Truly Help Patients Stop Basal Insulin?

Explore why adding GLP-1 RAs to basal insulin does not improve rates of insulin discontinuation in type 2 diabetes compared to oral diabetes therapies.

Jul 15, 2026
3 min read
Indian doctor discussing Tighter Dietary Supplement Rules: ACP Calls for Action

Tighter Dietary Supplement Rules: ACP Calls for Action

Discover the ACP’s new policy recommendations to improve dietary supplements safety and how these reforms impact clinical practice in India and globally.

Jul 15, 2026
3 min read
Indian doctor discussing Do GLP-1 Agonists Raise Ischemic Optic Neuropathy Risk?

Do GLP-1 Agonists Raise Ischemic Optic Neuropathy Risk?

This target trial emulation explores the link between GLP-1 receptor agonists and ischemic optic neuropathy risk in type 2 diabetes patients.

Jul 15, 2026
4 min read
Indian doctor discussing Do GLP-1 Receptor Agonists Cause Sudden Vision Loss?

Do GLP-1 Receptor Agonists Cause Sudden Vision Loss?

A nationwide cohort study evaluates the risk of NAION associated with GLP-1 receptor agonists compared to SGLT-2 inhibitors in type 2 diabetes.

Jul 14, 2026
3 min read
Indian doctor discussing Do GLP-1s Really Help Type 2 Diabetes Patients Stop Insulin?

Do GLP-1s Really Help Type 2 Diabetes Patients Stop Insulin?

A target trial emulation reveals that GLP-1 receptor agonists do not increase insulin discontinuation rates compared to oral diabetes therapies.

Jul 14, 2026
3 min read
Indian doctor discussing Is Your Patient’s Supplement Safe? ACP Demands Reform

Is Your Patient’s Supplement Safe? ACP Demands Reform

The ACP calls for stricter dietary supplement regulation to protect public health. Learn how these updates affect safety standards and patient care.

Jul 14, 2026
3 min read
Indian doctor discussing Are GLP-1 Receptor Agonists Harming Patient Vision?

Are GLP-1 Receptor Agonists Harming Patient Vision?

This target trial emulation explores whether GLP-1 receptor agonists increase the risk of ischemic optic neuropathy in patients with type 2 diabetes.

Jul 14, 2026
3 min read
Indian doctor discussing YEARS Algorithm Safely Spares CTPA in Cancer Patients

YEARS Algorithm Safely Spares CTPA in Cancer Patients

Learn how the YEARS algorithm in cancer safely reduces the need for CTPA imaging by twenty-two percent in patients with suspected pulmonary embolism.

Jul 13, 2026
3 min read
Indian doctor discussing How Amyloid Clearance Halts Alzheimer’s Brain Decay

How Amyloid Clearance Halts Alzheimer’s Brain Decay

This clinicopathologic case report analyzes how amyloid clearance from anti-amyloid therapies reduces downstream tau pathology in Alzheimer disease.

Jul 13, 2026
3 min read
Indian doctor discussing Is Aspirin Alone Enough After Hip or Knee Arthroplasty?

Is Aspirin Alone Enough After Hip or Knee Arthroplasty?

Learn why aspirin alone is safe and effective for postoperative thromboprophylaxis after total hip or knee replacement, according to the EPCAT III study.

Jul 13, 2026
3 min read
Indian doctor discussing Is Left Atrial Appendage Closure Safe for High-Risk AF?

Is Left Atrial Appendage Closure Safe for High-Risk AF?

A recent study shows left atrial appendage closure is not noninferior to medical therapy for patients with atrial fibrillation at high risk of stroke.

Jul 8, 2026
3 min read